Which PASI Outcome Is Most Relevant to the Patients in Real-World Care?

In psoriasis treatment, there is a high need to define meaningful endpoints and differences from the patient perspective to analyze patient-relevant differences of frequently used outcome methods for psoriasis under real-world conditions. A sample of 3116 patients from the German Psoriasis-Registry...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Natalia Kirsten, Stephan Rustenbach, Ralph von Kiedrowski, Christina Sorbe, Kristian Reich, Matthias Augustin
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/1fecd4a7fbea48b1b84b0c4e46c7201e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1fecd4a7fbea48b1b84b0c4e46c7201e
record_format dspace
spelling oai:doaj.org-article:1fecd4a7fbea48b1b84b0c4e46c7201e2021-11-25T18:10:42ZWhich PASI Outcome Is Most Relevant to the Patients in Real-World Care?10.3390/life111111512075-1729https://doaj.org/article/1fecd4a7fbea48b1b84b0c4e46c7201e2021-10-01T00:00:00Zhttps://www.mdpi.com/2075-1729/11/11/1151https://doaj.org/toc/2075-1729In psoriasis treatment, there is a high need to define meaningful endpoints and differences from the patient perspective to analyze patient-relevant differences of frequently used outcome methods for psoriasis under real-world conditions. A sample of 3116 patients from the German Psoriasis-Registry PsoBest was analyzed for clinical as well as patient-reported outcomes (PRO) after 3- and 6-month treatment. The parameters PASI, DLQI, and PBI were intercorrelated and related to two anchoring variables: (1) patient satisfaction with treatment and (2) perceived complete clearance. Baseline data were as follows: PASI 10.5 ± 9.1, DLQI 12.4 ± 3.4, and PBI 2.7 ± 0.3. There was an almost linear relationship between “complete patient satisfaction” and the relative differences in PASI in the range from PASI 25 to PASI 90. However, there was no additional benefit between PASI 90 and PASI 100. The same finding resulted from the anchoring variable “perception of complete healing”. When related to DLQI outcomes, relative PASI changes as well as absolute changes and PASI at 3 and 6 months showed relevant differences between the PASI classes 25 to 90 but not between PASI 90 and PASI 100. Under real-world conditions, changes in PASI and DLQI reflect patient-relevant benefits.Natalia KirstenStephan RustenbachRalph von KiedrowskiChristina SorbeKristian ReichMatthias AugustinMDPI AGarticlepsoriasisoutcomes measurementpreferencesbenefitsregistryScienceQENLife, Vol 11, Iss 1151, p 1151 (2021)
institution DOAJ
collection DOAJ
language EN
topic psoriasis
outcomes measurement
preferences
benefits
registry
Science
Q
spellingShingle psoriasis
outcomes measurement
preferences
benefits
registry
Science
Q
Natalia Kirsten
Stephan Rustenbach
Ralph von Kiedrowski
Christina Sorbe
Kristian Reich
Matthias Augustin
Which PASI Outcome Is Most Relevant to the Patients in Real-World Care?
description In psoriasis treatment, there is a high need to define meaningful endpoints and differences from the patient perspective to analyze patient-relevant differences of frequently used outcome methods for psoriasis under real-world conditions. A sample of 3116 patients from the German Psoriasis-Registry PsoBest was analyzed for clinical as well as patient-reported outcomes (PRO) after 3- and 6-month treatment. The parameters PASI, DLQI, and PBI were intercorrelated and related to two anchoring variables: (1) patient satisfaction with treatment and (2) perceived complete clearance. Baseline data were as follows: PASI 10.5 ± 9.1, DLQI 12.4 ± 3.4, and PBI 2.7 ± 0.3. There was an almost linear relationship between “complete patient satisfaction” and the relative differences in PASI in the range from PASI 25 to PASI 90. However, there was no additional benefit between PASI 90 and PASI 100. The same finding resulted from the anchoring variable “perception of complete healing”. When related to DLQI outcomes, relative PASI changes as well as absolute changes and PASI at 3 and 6 months showed relevant differences between the PASI classes 25 to 90 but not between PASI 90 and PASI 100. Under real-world conditions, changes in PASI and DLQI reflect patient-relevant benefits.
format article
author Natalia Kirsten
Stephan Rustenbach
Ralph von Kiedrowski
Christina Sorbe
Kristian Reich
Matthias Augustin
author_facet Natalia Kirsten
Stephan Rustenbach
Ralph von Kiedrowski
Christina Sorbe
Kristian Reich
Matthias Augustin
author_sort Natalia Kirsten
title Which PASI Outcome Is Most Relevant to the Patients in Real-World Care?
title_short Which PASI Outcome Is Most Relevant to the Patients in Real-World Care?
title_full Which PASI Outcome Is Most Relevant to the Patients in Real-World Care?
title_fullStr Which PASI Outcome Is Most Relevant to the Patients in Real-World Care?
title_full_unstemmed Which PASI Outcome Is Most Relevant to the Patients in Real-World Care?
title_sort which pasi outcome is most relevant to the patients in real-world care?
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/1fecd4a7fbea48b1b84b0c4e46c7201e
work_keys_str_mv AT nataliakirsten whichpasioutcomeismostrelevanttothepatientsinrealworldcare
AT stephanrustenbach whichpasioutcomeismostrelevanttothepatientsinrealworldcare
AT ralphvonkiedrowski whichpasioutcomeismostrelevanttothepatientsinrealworldcare
AT christinasorbe whichpasioutcomeismostrelevanttothepatientsinrealworldcare
AT kristianreich whichpasioutcomeismostrelevanttothepatientsinrealworldcare
AT matthiasaugustin whichpasioutcomeismostrelevanttothepatientsinrealworldcare
_version_ 1718411485029335040